---
layout: minimal-medicine
title: Hemin
---

# Hemin
### Generic Name
Hemin

### Usage
Hemin is primarily used to manage recurrent attacks of acute intermittent porphyria (AIP) in women who experience these attacks in relation to their menstrual cycle.  It's a treatment option *after* initial carbohydrate therapy (typically high-glucose diets) has proven inadequate or is suspected to be insufficient.  Hemin is not a preventative medication; it's used to treat acute attacks.

### Dosage

**Adults (Acute Intermittent Porphyria Attack):**

* **Intravenous (IV) Infusion:** The dosage varies considerably depending on the severity of the attack and the patient's response.  Common regimens involve 1-4 mg/kg/day infused over 10-15 minutes, for 3-14 days.  In severe cases, this dose may be repeated every 12 hours or more.  A maximum daily dose of 6 mg/kg should not be exceeded. Alternatively, some protocols administer 3-4 mg/kg once daily for four days.  The decision on the appropriate dosage and duration should be made by a physician based on individual needs and response.

* **Alternative Regimen:**  Some sources suggest 3-4 mg/kg once daily for 4 days.


**Children and Adolescents:**

* Hemin's safety and efficacy have not been established in girls under 16 years of age.  For adolescent females aged 16 and older experiencing an acute attack of AIP, the usual IV dose is 3-4 mg/kg/day once daily for four days.  Higher frequency or dosage might be necessary for severe cases, but intervals should be at least 12 hours apart. The maximum daily dose remains 6 mg/kg.

**Dosage Adjustments:**  The manufacturer's labeling does not provide specific dosage adjustments for hepatic (liver) or renal (kidney) impairment.


### Side Effects

* **Common:** Fever (pyrexia)
* **Less Common, but Potentially Serious:**
    * Blood clotting abnormalities (coagulopathy), including decreased hematocrit, low fibrinogen levels, increased prothrombin time and partial thromboplastin time, and thrombocytopenia (low platelet count)
    * Inflammation of the vein at the injection site (phlebitis)
    * Increased white blood cell count (leukocytosis)
    * Renal effects (ranging from mild to reversible renal shutdown with oliguria)
    * Iron overload (with repeated administrations)

**Important:** Any new or worsening symptoms should be reported to a healthcare provider immediately.


### How it Works
Hemin inhibits the production of aminolevulinic acid synthase, a key enzyme in the pathway that produces porphyrins.  By reducing porphyrin production, hemin helps to alleviate the symptoms of acute intermittent porphyria attacks.  The mechanism involves influencing the balance of heme and porphyrin biosynthesis within the liver and bone marrow.

### Precautions

* **Contraindications:** Hemin is contraindicated in individuals with a known hypersensitivity (allergy) to hemin or any component of the formulation.
* **Drug Interactions:** Hemin can increase the effect of anticoagulants (blood thinners), and barbiturates or estrogen derivatives may reduce its effectiveness.  These combinations should be avoided or carefully managed under a physician's supervision.
* **Specific Populations:**  Use during pregnancy should be approached cautiously and only if the potential benefits outweigh the risks.  Breastfeeding mothers should discuss the risks and benefits of continued breastfeeding with their doctor.  Safety and efficacy haven't been established in children under 16.
* **Warnings:**  Hemin can cause transient, mild anticoagulation effects, and repeated administrations may lead to iron overload. Renal effects are possible, ranging from mild to severe (reversible renal shutdown).


### FAQs

* **Q: How is Hemin administered?** A: Hemin is administered intravenously (IV) by infusion.

* **Q: How long does it take to work?** A:  The onset of effect varies depending on the severity of the attack, but prompt administration is crucial for optimal outcomes.  It's not a quick fix and may take time to see full symptom relief.

* **Q: How is Hemin stored?** A: Refer to the specific storage instructions on the product labeling.  Generally, it requires refrigeration.

* **Q: Are there long-term effects?** A: Long-term effects are less well-defined, and regular monitoring for potential iron overload and renal effects is vital for patients receiving multiple treatments.

* **Q: What if I miss a dose?** A: Contact your physician immediately for guidance; do not attempt to adjust the dosage schedule independently.

* **Q: Is Hemin a cure for acute intermittent porphyria?** A: No, Hemin treats acute attacks but does not cure the underlying condition.  Lifestyle management and adherence to a physician's recommendations remain crucial.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice. Always consult your healthcare provider for any health concerns or before making any decisions related to your health or treatment.  The information provided here may not be exhaustive, and specific details may vary based on the product's formulation and the most current prescribing information.
